Senior Finance Director, A&D and Transitions, Orthopedics
Johnson & Johnson Innovative Medicine
Summary
Johnson & Johnson is recruiting for the position of Senior Finance Director, Acquisition and Divestiture (A&D) Operations & Transitions. This role is based in Bridgewater NJ, Raynham, MA, or West Chester, PA. This role may require periodic travel to US and International locations of not more than 25%.
Job description
Position Summary
Be part of an organization charged with acquisition integration and divestiture separation financial operations which has a direct and material impact on shareholder value creation. As a senior finance leader, you will shape enterprise-level strategy, influence the most significant transactions in the portfolio, and serve as a trusted advisor to executive leadership. The Senior Finance Director, A&D Operations & Transitions, will have global leadership and strategic ownership of the finance transformation and finance-related separation activities of Depuy Synthes, reporting to the CFO and serving as a key member of the finance leadership team. This leader will set the vision, operating model and governance for A&D finance, and will lead a global team of finance leaders and professionals.
Key Responsibilities: Separation
- Set the strategy for and provide executive leadership of integration workstreams to separate Depuy Synthes from J&J's financial landscape, representing Finance in the Integration Management Office (IMO) and serving as the senior Finance voice to the CFO, executive leadership and steering committees
- Hold end-to-end accountability for the planning, execution and delivery of all financial integration workstreams including: Opening Balance Sheet, Financial Planning & Analysis (FP&A), Employee Enablers, Supply Chain Finance, Tax, Treasury, Audit & Compliance, Financial Systems & Technology, Payroll, and Global Services implementation
- Hold ownership of integration cost management and accountability for delivery in alignment with the deal model budget, providing regular financial reporting and risk visibility to senior leadership
- Institutionalize after-action reviews (AAR) to capture best practices and lessons learned and ensure integration teams document new capabilities, tools and templates within the A&D Operations Acquisition Playbook
Key Responsibilities: Divestitures
- Set the finance strategy and lead the planning and execution of all financial workstreams to separate assets or businesses from J&J's financial landscape, playing a significant role in the marketing process, engaging with senior executives and external stakeholders, and representing Finance in the Transition Management Office (TMO)
- Provide executive oversight of carve-out processes to compile Quality of Earnings (QoE) and working capital financial analyses for auditor/buyer review, including leadership of financial diligence preparation, virtual data room population, buyer requests for information during due diligence and if applicable, ownership of the process to complete audited financial statements
- Provide critical finance review and negotiation support of transaction legal documents, such as SAPA/APA, TSA, TMA, and advise senior leadership on financial terms, risks and exposures
- Direct the development of stand-alone / stand up analyses applicable for financial buyers, coordinating with cross-functional business partners and GS to determine current state allocations and future state stand-alone cost models
- Define current state financial operating models and shape the 'to be' transition financial operating model in collaboration with external buyers, negotiating and aligning key decisions with senior stakeholders
- Set closing and cutover strategies to ensure business continuity for financial processes, controls and reporting
- Direct stranded cost analyses and mitigation strategies and present them to BUF and/or Finance leadership
- Provide senior financial oversight over deal accounting activities in coordination with BUF, GTAAS and PwC
- Institutionalize after-action reviews (AAR) to capture best practices and lessons learned and ensure separation teams document any capabilities, tools and templates within the A&D Operations Divestiture Playbook
Key Responsibilities: Other Transformation
- Provide strategic direction for change and risk management of A&D project plans, and lead the identification and development of execution plans involving any new transformation plan
- Own and drive accountability for A&D project specific financial commitments and outcomes, and report progress, risks and value delivery to the CFO and executive leadership
- Define the interaction model and governance related to finance projects working in partnership with the FS&T organization, and influence enterprise-wide finance transformation priorities
- Lead, develop, and retain a global team of finance leaders and professionals, building a robust talent pipeline and succession plans and creating opportunities for career growth and leadership development within the A&D team
- Foster a high-performance, inclusive culture, promoting innovation, agility, and collaboration, ensuring the team is equipped to meet the challenges of the dynamic M&A landscape
Requirements
- A minimum of a bachelor's degree, preferably with a major in Finance, Accounting, Business Administration, or a related field is required
- A minimum of twelve (12) years of progressive finance or accounting business experience, including significant experience in senior leadership roles, is required
- Exceptional financial acumen and a deep understanding of finance processes (budgeting, forecasting, reporting) with the ability to translate complex financial data into strategic business insights and recommendations for executive leadership is required
- Advanced knowledge of general finance/accounting processes and understanding of GAAP / WWP's is required
- Demonstrated experience leading and developing leaders and large, global or multi-functional teams, with a passion for people management/talent development and succession planning, is required
- Ability to inspire and guide teams working on large-scale, complex programs and foster a culture of innovation, simplification and continuous improvement is required
- Exceptional communication, executive presence and influencing skills with the ability to build and maintain trusted cross-functional partnerships and influence at all levels, including senior executives, is required
- Proven ability to operate with a high degree of independence and to set strategy, plan, lead, prioritize, problem-solve and collaborate in a highly matrixed, complex global environment is required
- Advanced degrees (MBA, Master's in Finance, or similar) and/or professional certifications (CPA, CFA, CMA) are preferred
- Prior experience leading transformational and value creating programs such as business transformations, growth programs or A&D projects of significant scale and complexity is preferred
- Prior experience representing Johnson & Johnson externally and influencing and negotiating with external third parties, including buyers, advisors and auditors, is preferred
- Intellectual curiosity in technology integration and emerging technologies / solutions that drive digital transformation, improve efficiency and enhance financial performance is preferred
Benefits
- Health insurance
- Wellness programs
- Career development
- Life journey support
Company overview
Johnson & Johnson Innovative Medicine is the pharmaceutical division of Johnson & Johnson, leading the way in medical innovation with a relentless focus on bringing transformational treatments to patients worldwide. The company applies rigorous science and compassion to address the most complex diseases of our time, developing groundbreaking medicines across key therapeutic areas including oncology, immunology, neuroscience, and cardiopulmonary medicine. With deep expertise and global reach, Johnson & Johnson Innovative Medicine reimagines how devastating diseases are treated and cured, delivering hope and better care for millions of patients and their families. The organization pioneers the path from laboratory research to clinical application, championing patients every step of the way while maintaining an unwavering commitment to scientific excellence and patient-centered innovation.